Table 2 Entry selection criteria of the control group (B) patients
Patient | Age | Gender | CKD | Weight | Comorbidities | UACR | S. Creat. | Bl. Urea | e-GFR |
|---|---|---|---|---|---|---|---|---|---|
No/G | Yrs | years | Kgm. | mg/g | mg/dl | mg/dl | ml/min. | ||
1/B | 38 | M | 7 | 72 | IN, HTN | 1266 | 3.5 | 112 | 36 |
2/B | 36 | F | 11 | 67 | DM, SLE, HTN | 1427 | 3.3 | 114 | 34 |
3/B | 32 | M | 6 | 65 | DM, HTN | 1562 | 3.2 | 123 | 31 |
4/B | 40 | F | 5 | 68 | IN, HTN | 1673 | 3.7 | 121 | 32 |
5/B | 28 | F | 7 | 73 | DM, SLE | 1458 | 3.1 | 134 | 41 |
6/B | 36 | M | 6 | 66 | IN, HTN | 1403 | 3.5 | 132 | 32 |
7/B | 37 | F | 6 | 67 | HTN | 1643 | 3.1 | 123 | 36 |
8/B | 33 | F | 9 | 72 | IN, HTN | 1474 | 3.4 | 122 | 34 |
9/B | 32 | F | 11 | 64 | SLE, DM | 1372 | 3.1 | 132 | 38 |
10/B | 29 | M | 6 | 67 | SLE, HTN | 1575 | 3.3 | 147 | 31 |
11/B | 31 | F | 8 | 62 | HTN | 1644 | 3.5 | 114 | 34 |
12/B | 37 | F | 9 | 69 | DM, HTN | 1733 | 3.8 | 123 | 24 |
13/B | 34 | M | 7 | 64 | DM | 1376 | 2.6 | 125 | 39 |
14/B | 37 | M | 12 | 65 | DM, HTN | 1773 | 3.4 | 124 | 38 |
15/B | 38 | F | 11 | 66 | HTN | 1352 | 3.6 | 117 | 39 |
16/B | 28 | M | 9 | 69 | SLE, HTN | 1467 | 3.6 | 126 | 36 |
17/B | 41 | M | 5 | 64 | DM | 1463 | 2.7 | 134 | 36 |
18/B | 32 | M | 7 | 73 | SLE, HTN | 1423 | 2.7 | 126 | 39 |
19/B | 37 | F | 8 | 65 | DM, IN | 1378 | 3.5 | 113 | 35 |
20/B | 29 | M | 8 | 73 | HTN | 1748 | 3.3 | 98 | 29 |